glp 1 select trial GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 Agonists For Obesity In

Available at Watsons and SM Dept

Researchers employ the peptide in in vitro and ex vivo models to probe the signaling cascades that regulate dendritic spine density, synaptic connectivity, and long-term potentiation

doi: 10.1016/j.celrep.2025.116234 78 SvobodovLSedlcekJmahelovZMajerPMacharaAakovKG

What we know Some randomized controlled trials have demonstrated that addition of supplemental L-carnitine to standard medical therapy improves measures of exercise tolerance and heart pumping ability in patients with heart failure

They are designed to work alongside a healthy lifestyle that includes proper nutrition, regular movement, and adequate sleep